// DAO Tokens — invest in research DAOs that, post-patent or product, generate revenue.
// 3 screens: directory, DAO detail, my holdings + active proposals.
function DAORail({ active }) {
return (
<>
);
}
// ────────────────────────────────────────────────────── DAO DETAIL ───────────
function DAOTokenDetailDapp() {
return (
}>
}
title="$AGEX · AgeX Longevity DAO"
sub="A senolytic-discovery DAO with two granted patents and a commercial pilot underway. 4,210 members, $42.4M treasury, $3.4M TTM revenue paid through the contract."
actions={<>
Charter · whitepaperWatchlistBuy $AGEX · $2.42
>}
/>
{/* Left column */}
Mark
$2.42
24h
+5.1%
Mkt cap
$240M
FDV
$420M
Holders
4,210
AgeX exists to industrialise senolytic discovery: small molecules that selectively eliminate senescent cells implicated in age-related disease. The DAO has assembled a 14-member discovery pipeline — using its own AI hypothesis agent — that has shipped two granted USPTO patents, with a third in examination. Revenue is generated by license-back arrangements with pharmaceutical partners and direct-to-consumer assays produced by the DAO's wet-lab subsidiary.